Wells Fargo & Company »

Onkure Therapeutics Inc-a shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Onkure Therapeutics Inc-a (OKUR) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Onkure Therapeutics Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Onkure Therapeutics Inc-a held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Onkure Therapeutics Inc-a by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $26k 9.5k 2.75
2025-06-30 $18k 7.6k 2.39
2025-03-31 $16k 3.6k 4.30
2024-12-31 $14k 1.6k 8.60

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Onkure Therapeutics Inc-a

Acorn Capital Advisors
Citadel Advisors
Shay Capital
Vanguard Group
Highbridge Capital Management
Vestal Point Capital
BlackRock
StepStone
Cantor Fitzgerald, L. P.
NEA Management Company
Carlyle
Prosight Management
Renaissance Technologies
Rangeley Capital
Tang Capital Management

View all funds holding Onkure Therapeutics Inc-a